THE 'WHY'
There is a lot of data indicating the rising prevalence of cardiovascular diseases across Europe. In Spain, which is our current location for this project, a study from 2015 stated that CVD-related deaths outperform cancer and respiratory diseases (1). More specifically, there are an estimated 924,000 patients in a situation of secondary prevention after a cardiovascular event, where secondary prevention refers to helping the patient manage the disease after an incident.
Also, while the healthcare costs in Spain had been around 6 billion euros (2) due to premature death, nowadays the mortality rate from cardiovascular diseases is decreasing in most EU countries. Thus more people live with disability and chronicity caused by CVDs, leading to more costs upon the healthcare system.
One of the challenges that weights heavy consequences on both the patient and the healthcare system, resulted from our desk research and expert interviews, was adherence to treatment for patients. It seems that “In Spain, the health care and economic cost of failing to adhere was shown in a recent study that indicated that, by adding just one percentage point to the completion of therapy for the secondary prevention of cardiovascular diseases, would involve an avoidable cost of 10,900,627 euros to public health care. Furthermore, an increase of 10 percentage points in improving adherence would prevent 8,700 deaths and 7,650 episodes caused by CVD, with an avoidable cost of 75 million euros to the health care system.” [emphasis added] (3)
Furthermore, a health expert from Barcelona’s eHealthCenter confirmed that adherence to treatment is an important and difficult challenge faced by the healthcare system. He indicated that many people received information about how to manage their health, but very few are capable (know how) to act upon this information. Defying adherence more clearly, according to the World Health Organization, it is described as the extent to which a person's behavior—taking medication, following a diet, and/or executing lifestyle changes, corresponds with agreed recommendations from a health care provider(4).
From the literature, we know that adherence involves a complex behavioral process that requires: “the active, voluntary, and collaborative involvement of the patient in a course of behavior to produce a therapeutic result.” Also, poor adherence to a treatment seems to be a significant barrier in the secondary prevention of cardiovascular disease (CVD) and, as a result, in being able to reach certain levels of health care excellence (5). The reasons for abandoning the treatment could be the patient’s lack of perception of his or her vulnerability, the patient’s lack of information on the treatment and the lack of precise instructions from health care professionals. (6)
EXPLORING THE LOCAL CONTEXT - SPAIN
Around the topic of cardiovascular health, in Spain, and Barcelona in particular, we have found several actors that are active in this area, ranging from hospitals to patient associations, professional cooking workshops for cardiovascular patients, social media groups, academic research institutes, health apps (example 1, example 2), and even local initiatives.
Also, a recent survey (7) across the country discovers that :
This type of study gives us an overview on how people with CVD behave, and although we don’t have a clear picture of their personal motives, circumstances of why they behave as such, we can assume that the reasons for non-adherence are related to not knowing how to bridge the intention-action gap (8), meaning how to act upon the information they receive from the doctors.
Also the presence of different actors in the Spanish context shows great initiatives, and the data from above indicates growing initiatives in Spain and Barcelona in particular for CVD. However, the actors and their activities are fragmented, there is a lack of clear information and instructions form the medical side to the patient but also vice-versa, meaning a passive role from the patient in his health care, indicated the eHealthCenter expert on behavioral health.
WHO ARE WE DESIGNING FOR?
The common group of people who suffers an cardiovascular incident in Spain is: men, around 66 years old, with primary studies, retired, living with a partner (7).
Influenced by this piece of data, our target group is related to people:
HOW WE INTEND TO SOLVE THE CHALLENGE?
For a long time, healthcare professionals have focused on information-giving interventions, hoping that their patients might change and respect their treatment, including changing their lifestyles. However, looking at recents developments in behavioral sciences (the why)(8), structured frameworks to help people change their behavior are starting to appear (see 9). Solutions in behavioral sciences (especially behavior design, see 9,10, 11) demonstrate the effectiveness of interventions using behavioral science insights in healthcare.
Example:
The authors of this study encouraged stroke victims to take their warfarin pills via lotteries, designed in reactance to the serious issue of patients not taking their medicine correctly. The treatment group had a 1% chance of winning $100 contingent upon taking their pills correctly. The control group did not have any incentives to take their pills correctly beyond the threat of dying. Adherence in the treatment group was almost 100% compared to 80% in the control (though with the caveat that the sample size is very small, N=20). (Volpp et al. (2008), A test of financial incentives to improve warfarin adherence, BMC Health Services Research ).
In Barcelona, behavioral change is starting to appear at a very theoretical level in centers like the eHealthCenter. One way we could approach this challenge is to use techniques from behavioral science in order to design an intervention for people who just had a cardiovascular incident, aimed at the patient (after understanding more his context, support system, habits and behaviors), with an impact on the surrounding family. We are striving to use evidence-based techniques that help people make lifestyles changes, that are not based on the idea of motivating people or just giving them information. We know, from psychological studies, that this does not work. These techniques could imply different ways of solving the problem of non-adherence. For example, in Spain there is a big culture of people buying tickets for lottery. As we have seen in the study above by Volpp et al. (2008), these kind of interventions can significantly improve adherence. We can connect with institutions like the eHealthCenter, banks, design firms who can help us design for adherence, in a scientific, human and empowering way.
References
1. Instituto Nacional de Estadística (INE): Defunciones según la causa de muerte 2015. Defunciones por causas (lista detallada) sexo y edad. Disponible en: http://www.ine.es/jaxi/Tabla.htm?path=/t15/p417/a2015/l0/&file=01000.px&L=0
2. Centre for Economics and Business Research. The rising cost of cvd 2014. Available at:
https://cebr.com/reports/the-rising-cost-of-cvd
3. Gutiérrez-Angulo, M. L., Lopetegi-Uranga, P., Sánchez-Martín, I., & Garaigordobil Landazabal, M. (2012). Cumplimiento terapéutico en pacientes con hipertensión arterial y diabetes mellitus 2. Revista de Calidad Asistencial, 27(2), 72–77. https://doi.org/10.1016/j.cali.2011.09.008
4. Phan K, Gomez YH, Elbaz L, Daskalopoulou SS. Statin treatment non-adherence and discontinuation: clinical implications and potential solutions. Curr PharmDes. 2014;20:6314-24
5. López-Sendón J, González-Juanatey JR, Pinto F, Cuenca Castillo J, Badimón L, Dalmau R, et al. Indicadores de calidad en cardiología. Principales indicadores para medir la calidad de los resultados (indicadores de resultados) y parámetros de calidad relacionados con mejores resultados en la práctica clínica (indicadores de práctica asistencial). INCARDIO (Indicadores de Calidad en Unidades Asistenciales del Área del Corazón): Declaración de posicionamiento de consenso de SEC/SECTCV. Rev Esp Cardiol. 2015;68:976-995.e10.
6. Cardiovascular patients’ declaration regarding therapeutic adherence
7. Informe de la situaciónde la hipercolesterolemiay otros factores de riesgoen pacientes con altoy muy alto riesgo vascularen España, 2019, Cardioalianza (https://cardioalianza.org/wp-content/uploads/2019/12 Informe_hipercolesterolemia_factores_riesgo.pdf)
8 Saugato Datta and Sendhil Mullainathan. 2012. "Behavioral Design: A New Approach to Development Policy." CGD Policy Paper 016. Washington DC: Center for Global Development.http://www.cgdev.org/content/publications/detail/1426679
9.Ten Conditions for Change - a framework for creating positive behaviors 10.Applying behavioural insight to health
11. B.F. Skinner Award Lecture for Organizational Behavior Management: “Designing Sustainable Behavior Change” https://vimeo.com/174549164